Management of Per Rectal Bleeding in Patients on Dual Antiplatelet Therapy

Immediate Actions

The American Heart Association recommends continuing aspirin without interruption in patients with per rectal bleeding, as the mortality benefit from preventing recurrent stroke outweighs bleeding risk, especially in patients only 20 days post-CVA 1, 2
The American College of Gastroenterology suggests temporarily withholding the P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) until endoscopic hemostasis is achieved 1, 2
The European Society of Cardiology advises against discontinuing both antiplatelet agents simultaneously, as this is associated with a high risk of cerebrovascular thrombosis 1
Initiate intravenous fluid resuscitation immediately, and transfuse packed red blood cells only if hemodynamic instability persists (hypotension, tachycardia) 1
Administer high-dose intravenous proton pump inhibitors immediately upon presentation (e.g., 80mg IV bolus followed by 8mg/hour infusion) 1, 2

Perform endoscopy within 12 hours while continuing aspirin, as classified as urgent/emergent endoscopy given active bleeding 1, 2
The procedure can be safely performed on aspirin monotherapy, and achieve endoscopic hemostasis using appropriate techniques (clips, thermal therapy, injection therapy) 2, 1
Document quality of hemostasis achieved 2

Resume aspirin the same day if it was held, and resume the P2Y12 inhibitor within 5 days after confirmed endoscopic hemostasis, as platelet function returns 5-7 days after discontinuation 1, 2
The specific timing depends on the quality of hemostasis and bleeding risk assessment 2
At 20 days post-ischemic CVA, the patient remains in an extremely high thrombotic risk period (within 6 months of stroke) 1
Early resumption of dual antiplatelet therapy is essential to prevent recurrent stroke 1

Prescribe proton pump inhibitors indefinitely to all patients continuing antiplatelet therapy after GI bleeding, as this substantially reduces risk of recurrent GI bleeding 1, 3
Use pantoprazole or esomeprazole preferentially if on clopidogrel, as omeprazole may reduce clopidogrel effectiveness through CYP2C19 inhibition 3, 4
Dual antiplatelet therapy is NOT routinely recommended for stroke prevention alone—it is indicated for acute coronary syndrome or recent coronary stent placement 4

Recent ischemic stroke (20 days ago) represents extremely high thrombotic risk, and the first 90 days post-stroke carry the highest risk of recurrence 1
The mortality benefit of continuing aspirin outweighs bleeding risk in secondary prevention 1
Recurrent ischemic stroke is generally more disabling and fatal than GI bleeding complications, and dual antiplatelet therapy beyond the acute period (21-90 days) increases major bleeding risk 2.22-fold compared to aspirin alone 1

Monitor hemoglobin levels at 1 week and 1 month post-discharge, and assess for signs of recurrent bleeding (melena, hematochezia, anemia) 5
Ensure stool occult blood testing is negative before hospital discharge 5